Research Protocol

Ipamorelin 10mg — Research Protocol

Dosage Calculator → How to Reconstitute →
Ipamorelin is a synthetic pentapeptide that acts as a potent and selective growth hormone secretagogue (GHS). Unlike other GH-releasing peptides such as GHRP-2 and GHRP-6, Ipamorelin demonstrates remarkable selectivity—it stimulates growth hormone release from the pituitary gland without causing significant increases in cortisol, prolactin, or appetite-stimulating hormones like ghrelin. This selectivity profile makes it one of the cleanest GH secretagogues available for research purposes. Developed initially by Novo Nordisk and later studied by various research groups, Ipamorelin binds to the ghrelin receptor (GHS-R1a) and triggers pulsatile GH release that closely mimics the body's natural secretion patterns. Research has demonstrated its potential applications in muscle development, fat metabolism, bone density, and recovery enhancement.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at 2–8 °C (35.6–46.4 °F) for short-term or −20 °C (−4 °F) for long-term storage in dry, dark conditions[10][11].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks with bacteriostatic water[12]. For longer storage, freeze aliquots at −20 °C (−4 °F) and avoid repeated freeze–thaw cycles[11].
  • Allow vials to reach room temperature before opening to reduce condensation uptake[10].

How It Works

Ipamorelin binds to the growth hormone secretagogue receptor (GHSR-1a) and stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner[1][2]. Unlike earlier growth hormone releasing peptides, ipamorelin is highly selective and does not significantly stimulate ACTH, cortisol, or prolactin release at effective doses[1][3]. After subcutaneous injection, GH levels peak within approximately 40 minutes and return to baseline by 2–3 hours[4]. This short-acting pulsatile effect makes it suitable for once-daily administration to support physiological GH patterns. Animal studies have shown that even chronic daily exposure did not significantly desensitize GH release mechanisms[5], though cycling is recommended as a precautionary measure. Ipamorelin has also demonstrated pro-motility effects in the gastrointestinal tract via GHSR-1a receptors, with preclinical and clinical studies showing it can accelerate gastric emptying[6].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Supports increases in lean body mass and improvements in recovery through GH-mediated anabolic processes[1][2].
  • Enhances fat metabolism and supports favorable body composition changes over time[1].
  • High selectivity for GH release with minimal impact on other hormones (ACTH, cortisol, prolactin)[1][3].
  • May support improved gastric motility and digestive function[6].
  • Generally well tolerated with a low incidence of side effects at typical doses[3].
  • Occasional mild injection-site reactions (redness, swelling) may occur; very rare reports of water retention or increased hunger.

Lifestyle Factors

Complementary strategies for best outcomes.

  • Pair with a balanced, protein-adequate diet to support muscle synthesis and recovery.
  • Combine resistance training and cardiovascular exercise to maximize anabolic and metabolic benefits.
  • Prioritize 7–9 hours of quality sleep nightly, as GH naturally peaks during deep sleep phases.
  • Manage stress levels, as chronic stress and elevated cortisol can blunt GH response.
  • Inject on an empty stomach (avoid food 2–3 hours before and 30–60 minutes after) to optimize GH release.

References

For laboratory and research use only. Minimum 98% purity. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. This protocol is provided for educational and research purposes only and is not medical advice. The purchaser accepts full responsibility for safe handling, storage and lawful use.